Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

NCT02500212 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Organ or Tissue Transplant; Complications

Interventions

DRUG: ENVARSUS®
DRUG: ADVAGRAF®

Sponsor

Chiesi Farmaceutici S.p.A.